Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 17, 2023

BUY
$21.54 - $24.41 $215,723 - $244,466
10,015 Added 64.97%
25,430 $575,000
Q2 2023

Jul 18, 2023

SELL
$12.62 - $24.47 $20,633 - $40,008
-1,635 Reduced 9.59%
15,415 $377,000
Q4 2022

Jan 17, 2023

BUY
$13.92 - $17.0 $34,800 - $42,500
2,500 Added 17.18%
17,050 $265,000
Q3 2022

Oct 14, 2022

BUY
$13.36 - $16.75 $4,342 - $5,443
325 Added 2.28%
14,550 $218,000
Q2 2022

Jul 12, 2022

BUY
$12.69 - $19.25 $38,387 - $58,231
3,025 Added 27.01%
14,225 $206,000
Q1 2022

Apr 07, 2022

BUY
$15.5 - $23.89 $22,087 - $34,043
1,425 Added 14.58%
11,200 $205,000
Q4 2021

Jan 13, 2022

BUY
$20.04 - $23.84 $195,891 - $233,036
9,775 New
9,775 $230,000

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Diversified Trust CO Portfolio

Follow Diversified Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.